MEDICOX Co. Ltd
MEDICOX Co., Ltd. operates in the shipbuilding equipment, electric motor, and generator businesses in South Korea and internationally. It produces blocks, such as bows, sterns, propeller bosses, and engine rooms for very large ships; and generators for ship power generation, as well as motors and traction motors. The company is also involved in the provision of customized manufacturing services, … Read more
MEDICOX Co. Ltd (054180) - Net Assets
Latest net assets as of March 2025: ₩56.22 Billion KRW
Based on the latest financial reports, MEDICOX Co. Ltd (054180) has net assets worth ₩56.22 Billion KRW as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩83.56 Billion) and total liabilities (₩27.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩56.22 Billion |
| % of Total Assets | 67.28% |
| Annual Growth Rate | 10.73% |
| 5-Year Change | 38.38% |
| 10-Year Change | 141.7% |
| Growth Volatility | 32.59 |
MEDICOX Co. Ltd - Net Assets Trend (2012–2024)
This chart illustrates how MEDICOX Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDICOX Co. Ltd (2012–2024)
The table below shows the annual net assets of MEDICOX Co. Ltd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩52.45 Billion | -15.73% |
| 2023-12-31 | ₩62.24 Billion | -1.59% |
| 2022-12-31 | ₩63.24 Billion | -4.48% |
| 2021-12-31 | ₩66.20 Billion | +74.69% |
| 2020-12-31 | ₩37.90 Billion | +79.05% |
| 2019-12-31 | ₩21.17 Billion | -0.27% |
| 2018-12-31 | ₩21.22 Billion | +28.25% |
| 2017-12-31 | ₩16.55 Billion | -13.42% |
| 2016-12-31 | ₩19.11 Billion | -11.92% |
| 2015-12-31 | ₩21.70 Billion | +4.61% |
| 2014-12-31 | ₩20.74 Billion | +34.34% |
| 2012-12-31 | ₩15.44 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MEDICOX Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2309.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩148.64 Billion | 283.42% |
| Total Equity | ₩52.45 Billion | 100.00% |
MEDICOX Co. Ltd Competitors by Market Cap
The table below lists competitors of MEDICOX Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SODEXO
MU:SJ7
|
$442.13K |
|
Avioane Craiova SA
RO:AVIO
|
$442.25K |
|
Profithol S.A.
MC:SPH
|
$443.00K |
|
IND.VAERDEN -A- (IDVA.SG)
STU:IDVA
|
$443.49K |
|
Quarta-Rad Inc
PINK:QURT
|
$441.96K |
|
PreAxia Health Care Payment Systems Inc
PINK:PAXH
|
$441.89K |
|
FIRSTENERGY
MU:FE7
|
$441.81K |
|
Aequus Pharmaceuticals Inc
OTCQB:AQSZF
|
$441.34K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDICOX Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 62,235,838,450 to 52,445,389,240, a change of -9,790,449,210 (-15.7%).
- Net loss of 21,434,919,780 reduced equity.
- New share issuances of 993,560,520 increased equity.
- Other factors increased equity by 10,650,910,050.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-21.43 Billion | -40.87% |
| Share Issuances | ₩993.56 Million | +1.89% |
| Other Changes | ₩10.65 Billion | +20.31% |
| Total Change | ₩- | -15.73% |
Book Value vs Market Value Analysis
This analysis compares MEDICOX Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.21x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.04x to 0.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩3976.22 | ₩153.00 | x |
| 2017-12-31 | ₩6577.67 | ₩153.00 | x |
| 2018-12-31 | ₩7157.82 | ₩153.00 | x |
| 2019-12-31 | ₩6871.87 | ₩153.00 | x |
| 2020-12-31 | ₩7876.47 | ₩153.00 | x |
| 2021-12-31 | ₩3498.99 | ₩153.00 | x |
| 2022-12-31 | ₩2476.08 | ₩153.00 | x |
| 2023-12-31 | ₩1537.18 | ₩153.00 | x |
| 2024-12-31 | ₩719.70 | ₩153.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDICOX Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -40.87%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -70.02%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.55x
- Recent ROE (-40.87%) is below the historical average (-21.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 38.23% | 28.86% | 0.44x | 3.01x | ₩4.36 Billion |
| 2014 | 17.41% | 20.28% | 0.37x | 2.30x | ₩1.54 Billion |
| 2015 | 4.77% | 5.30% | 0.41x | 2.19x | ₩-1.14 Billion |
| 2016 | -67.73% | -80.78% | 0.29x | 2.89x | ₩-14.86 Billion |
| 2017 | -10.78% | -12.77% | 0.27x | 3.17x | ₩-3.44 Billion |
| 2018 | -10.50% | -8.83% | 0.45x | 2.64x | ₩-4.35 Billion |
| 2019 | -9.77% | -19.97% | 0.18x | 2.79x | ₩-4.18 Billion |
| 2020 | -22.65% | -53.01% | 0.19x | 2.24x | ₩-12.37 Billion |
| 2021 | -36.15% | -137.17% | 0.17x | 1.55x | ₩-30.55 Billion |
| 2022 | -67.39% | -195.35% | 0.20x | 1.75x | ₩-48.94 Billion |
| 2023 | -55.32% | -128.10% | 0.28x | 1.55x | ₩-40.65 Billion |
| 2024 | -40.87% | -70.02% | 0.38x | 1.55x | ₩-26.68 Billion |
Industry Comparison
This section compares MEDICOX Co. Ltd's net assets metrics with peer companies in the Aerospace & Defense industry.
Industry Context
- Industry: Aerospace & Defense
- Average net assets among peers: $72,356,410,010
- Average return on equity (ROE) among peers: -7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDICOX Co. Ltd (054180) | ₩56.22 Billion | 38.23% | 0.49x | $442.04K |
| Oriental Precision & Engineering Co.Ltd (014940) | $110.13 Billion | 23.66% | 0.96x | $122.46 Million |
| Victek Co. Ltd (065450) | $31.96 Billion | 5.63% | 0.59x | $71.93 Million |
| SAMYUNG ENC Co. Ltd (065570) | $37.05 Billion | -112.73% | 1.16x | $3.25 Million |
| AeroSpace Technology of Korea (067390) | $57.81 Billion | 4.32% | 1.33x | $87.13 Million |
| Satrec Initiative Co. Ltd (099320) | $58.01 Billion | 8.01% | 0.34x | $421.09 Million |
| Inhwa Precision Co. Ltd (101930) | $189.62 Billion | 8.05% | 0.92x | $156.96 Million |
| Hizeaero Co. Ltd (221840) | $76.47 Billion | 4.80% | 0.80x | $20.27 Million |
| Kencoa Aerospace Corporation (274090) | $33.68 Billion | -22.46% | 1.21x | $138.76 Million |
| ASTech Co., Ltd. (453860) | $56.47 Billion | 16.80% | 0.58x | $17.73 Million |